Principal Financial Group Inc. Grows Stock Holdings in Cardinal Health, Inc. $CAH

Principal Financial Group Inc. lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 1.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 291,833 shares of the company’s stock after acquiring an additional 4,300 shares during the quarter. Principal Financial Group Inc.’s holdings in Cardinal Health were worth $61,667,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CAH. Redhawk Wealth Advisors Inc. boosted its holdings in Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after purchasing an additional 48 shares during the last quarter. HF Advisory Group LLC lifted its holdings in shares of Cardinal Health by 0.9% in the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after buying an additional 49 shares during the period. Kathmere Capital Management LLC boosted its stake in shares of Cardinal Health by 1.2% in the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after buying an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. grew its holdings in Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares during the period. Finally, V Square Quantitative Management LLC grew its holdings in Cardinal Health by 2.6% during the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after acquiring an additional 50 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.8%

NYSE CAH opened at $228.88 on Friday. The stock has a market capitalization of $53.61 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 1.10 and a beta of 0.49. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $243.21. The stock has a 50-day moving average of $215.36 and a 200 day moving average of $213.66.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period last year, the company earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were paid a $0.5158 dividend. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.50%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CAH shares. Morgan Stanley boosted their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Weiss Ratings cut shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Bank of America boosted their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Finally, Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $249.13.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.